FDA approves Ultragenyx's drug for rare form of rickets

(Reuters) - The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical Inc's treatment for a rare and inherited form of rickets, a condition that causes weak bones, the agency said on Tuesday.